Showing results (141-150 of 203) with videos related to

Sort By:
Pageof 21
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 3, 2025
Endometrioid borderline ovarian tumour: A multicentre analysis from the MITO-14 studyG Candotti, A Bergamini, M Perrone, et al.
International Journal of Oncology|July 31, 1998
Apolipoprotein A-I reverse transcriptase-polymerase chain reaction analysis for detection of hematogenous colon cancer disseminationN Normanno, A De Luca, A Castaldo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2001
Prognostic value of serum biological markers in patients with hepatocellular carcinomaR Parasole, F Izzo, F Perrone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2000
Phase I study with weekly cisplatin-paclitaxel and concurrent radiotherapy in patients with carcinoma of the cervix uteriS Pignata, P Frezza, S Tramontana, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2024
MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapyS Pignata, D Califano, D Lorusso, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 13, 2018
Trabectedin in Ovarian Cancer: is it now a Standard of Care?J Ventriglia, I Paciolla, S C Cecere, et al.
Anticancer Research|March 28, 2001
Carboplatin, cisplatin and paclitaxel in the treatment of patients with epithelial ovarian cancerS De Placido, S Tramontana, E Ferrari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2000
A phase I study of gemcitabine and epirubicin for the treatment of platinum-resistant or refractory advanced ovarian cancerS Pignata, E Varriale, G Casella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 5, 2003
An escalating dose finding study of liposomal doxorubicin and vinorelbine for the treatment of refractory or resistant epithelial ovarian cancerR Tambaro, S Greggi, R V Iaffaioli, et al.
Anticancer Research|August 21, 2003
Safety of cisplatin after severe hypersensitivity reactions to carboplatin in patients with recurrent ovarian carcinomaA Ottaiano, R Tambaro, S Greggi, et al.
Pageof 21